Jill Henrich, EVP, Global Head RA & Quality at Atara Biotherapeutics, Inc. (ATRA), sold 963 shares at $6.63 ($6K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Open-market sale of $6k ATRA by EVP, Global Head RA & Quality. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.63 | 132 | $875 | 13.7% |
| 2 | $6.63 | 831 | $6K | 86.3% |
| Total | $6.63 avg | 963 | $6K | 100% |
| Filing → |
| ATRA | SELL | 2024-05-20 | $16K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $3K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $1K | — | Filing → |